doctor head
  pharmacy and drugs  
search Search
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
  doctor legs  


Subscribe to our newsletter:
    Search results
Search results for: mylan

1 - 4 of 4 <<previous | next>>

Drugs results:

Fexofenadine tablets


Fexofenadine is an antihistamine that works against the naturally occurring chemical histamine in your body. Histamine is the chemical mediator for an allergic response. Antihistamine is also termed as antipruritic, “pruritus” means itchiness. It is a lon more...

Rosuvastatin pills


Rosuvastatin is an HMG CoA reductase inhibitor which is also known as “statins” group. A class of drug that works by blocking the production of cholesterol (a type of fat) in the body. Indications: for primary hypercholesterolemia (excessive choleteste more...



Nitrofurantoin is an antibiotic. It fights off bacteria in the body. Indications: treat urinary tract infections due to susceptible strains of Escherichia coli, Staphylococcus aureus and certain susceptible strains of Klebsiella, Enterobacter and more...



Levothyroxine is a hormone used to replace the hormone that is normally produced by your thyroid gland. This hormone is responsible for regulating the body's energy and metabolism. Levothyroxine is given when the thyroid gland does not produce enough of t more...

Diseases results:

Reduce cholesterol
Bladder infection
Thyroid cancer

Articles results:

U.S. District Court Grants Extension For Consideration Of Amlodipine Besylate Exclusivity
Mylan Laboratories Inc. (NYSE: MYL) today announced that the U.S. District Court for the District of Columbia has extended the deadlines pertaining to Mylan's request for a temporary restraining order in its lawsuit seeking to stop the U.S. Food and Drug Administration (FDA) from approving any other Amlodipine Besylate abbreviated new drug applications (ANDAs).

Mylan Laboratories To Acquire Generics Business Of Merck KGaA For 4.9 Billion Euros
Mylan Laboratories Inc. (NYSE: MYL) and Merck KGaA today announced the signing of a definitive agreement under which Mylan will acquire Merck's generics business ("Merck Generics") for EUR 4.9 billion ($6.7 billion) in an all-cash transaction. The combination of Mylan and Merck Generics will create a vertically and horizontally integrated generics and specialty pharmaceuticals leader with a diversified revenue base and a global footprint.

Texas Sues Three Drug Makers Alleging Medicaid Fraud
Texas on Wednesday filed lawsuits against Mylan Laboratories, Sandoz,

1 - 4 of 4 <<previous | next>>

© 2006-2010 All rights reserved.